(E)-5-Isopropyl-8-methylnona-6,8-dien-2-one
Common Name: |
(E)-5-Isopropyl-8-methylnona-6,8-dien-2-one |
IUPAC Name: |
(6E)-8-methyl-5-propan-2-ylnona-6,8-dien-2-one |
Molecular Formula: |
C13H20O3 |
SMILES: |
CC(C)C(CCC(=O)C)C=CC(=C)C |
Inchi: |
1S/C13H22O/c1-10(2)6-8-13(11(3)4)9-7-12(5)14/h6,8,11,13H,1,7,9H2,2-5H3/b8-6+ |
Inchi Key: |
PQDRXUSSKFWCFA-SOFGYWHQSA-N |
Cas No: |
2278-53-7 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
224.30 |
Mass (g/mol) |
194.167 |
Molar Refractivity |
63.50 |
Net Charge |
|
HBD |
|
HBA |
3 |
Rt Bonds |
6 |
Rings |
|
TPSA |
43.37 |
Hetero Atoms |
1 |
Heavy Atoms |
16 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
238.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.007 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.69 |
LogP |
3.76 |
iLOGP |
2.84 |
XLOGP3 |
1.92 |
WLOGP |
2.50 |
MLOGP |
1.95 |
ESOL Log S |
-2.04 |
ESOL Solubility (mg/ml) |
2.03 |
ESOL Solubility (mol/l) |
0.009 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.45 |
Ali Solubility (mg/ml) |
0.79 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.47 |
Silicos-IT Solubility (mg/ml) |
0.76 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.31 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.537 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.359 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |